Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function

Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age

(2016) Randall Hoover et al.   CLINICAL THERAPEUTICS

Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers

(2016) Randall Hoover et al.   CLINICAL THERAPEUTICS

Clinical Pharmacology of Delafloxacin in Patients With Hepatic Impairment

(2016) Randall Hoover et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Evolving Resistance Among Gram-positive Pathogens

(2015) Jose M. Munita et al.   CLINICAL INFECTIOUS DISEASES

Delafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacy

(2015) Françoise Van Bambeke   Future Microbiology

Novel antibiotics: Are we still in the pre–post-antibiotic era?

(2015) R. Draenert et al.   INFECTION

Disposition, metabolism and mass balance of delafloxacin in healthy human volunteers following intravenous administration

(2015) Andrew McEwen et al.   XENOBIOTICA

White Paper: Recommendations on the Conduct of Superiority and Organism-Specific Clinical Trials of Antibacterial Agents for the Treatment of Infections Caused by Drug-Resistant Bacterial Pathogens

(2012)   CLINICAL INFECTIOUS DISEASES